News Roche to file Actemra in inflamed artery disease Drug successful in late stage trial for giant cell arteritis
News Embattled Mylan files Herceptin biosimilar in US But senators call for investigation into EpiPen schools contracts.
Roche Roche muscling into melanoma with Tecentriq Swiss pharma looking to combine immunotherapy with already marketed drugs.
News Three's a crowd as Tecentriq approved in lung cancer Cancer immunotherapy approved in second line.
News FDA kicks off review of Takeda's narcolepsy hopeful The FDA has started a priority review of Takeda's oveporexton for sleep disorder narcolepsy, setting up a decision in the third quarter of the year.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
